| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.7B | $2.5B | $1.4B | $0.9B | $0.8B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.0B | $0.4B | $0.3B | $0.3B | $-0.2B | $-1.2B | $0.1B | $0.1B |
| Net Income | $-0.3B | $0.2B | $0.1B | $0.2B | $-0.5B | $-1.4B | $0.1B | $0.1B |
| EPS (Basic) | $-1.43 | $1.02 | $0.44 | $0.71 | $-1.95 | $-6.11 | $0.51 | $0.27 |
| EPS (Diluted) | $-1.43 | $1.01 | $0.44 | $0.71 | $-1.95 | $-6.11 | $0.51 | $0.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.7B | $9.2B | $9.4B | $9.7B | $9.7B | $10.6B | $11.3B | $9.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.4B | $0.7B | $0.9B | $0.7B | $1.0B | $0.3B | $0.4B |
| Total Liabilities | $4.6B | $5.6B | $5.7B | $5.4B | $5.3B | $5.7B | $4.8B | $3.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.1B | $3.6B | $3.8B | $4.3B | $4.5B | $4.9B | $6.5B | $5.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.5B | $0.4B | $-0.1B | $-0.4B | $0.5B | $0.4B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.2B | $0.1B | $0.4B | $0.1B | $-0.6B | $0.4B |
| Capital Expenditures | $0.3B | $0.2B | $0.3B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.4B | $-0.6B | $-0.5B | $-0.3B | $-0.5B | $0.9B | $0.1B | $-0.8B |